Alpha DNA Investment Management’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-2,941
Closed -$465K – 237
2024
Q2
$465K Buy
2,941
+684
+30% +$119K 0.18% 127
2024
Q1
$447K Sell
2,257
-63
-3% -$11.5K 0.17% 161
2023
Q4
$404K Buy
2,320
+812
+54% +$129K 0.16% 154
2023
Q3
$236K Buy
+1,508
New +$250K 0.1% 153
2021
Q2
– Sell
-117
Closed -$9K – 457
2021
Q1
$9K Sell
117
-48
-29% -$2.91K 0.01% 297
2020
Q4
$8K Buy
+165
New +$8.52K 0.01% 325

Other funds holding NUE

Alpha DNA Investment Management's NUE Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Nucor (NUE) in Q3 2024, closing a stake of 2,941 shares — an estimated $465K sold.

Alpha DNA Investment Management first reported a position in NUE in Q4 2020 and held it in 6 quarters. The position peaked at $465K in Q2 2024. 1,196 funds tracked by Wall St. Rank hold NUE as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Nucor position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,941 Nucor shares in Q3 2024, an estimated $465K.
  • Alpha DNA Investment Management first reported a position in Nucor in Q4 2020 and held it in 6 quarters.
  • Alpha DNA Investment Management's Nucor position peaked at $465K in Q2 2024.
  • 1,196 funds tracked by Wall St. Rank held Nucor as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.